Prognostic criteria in macular histoplasmic choroiditis

Area of Science:

• Ophthalmology
• Immunology

Background:

• Ocular inflammation can lead to vision loss.
• Histoplasmin sensitivity is associated with certain forms of ocular inflammation.
• Subclinical disease activity poses a risk for patients.

Purpose of the Study:

• To investigate the effect of histoplasmin desensitization on subsequent ocular disease activity.
• To evaluate the efficacy of prednisone in achieving remission of subclinical ocular inflammation.

Main Methods:

• A cohort study comparing patients undergoing histoplasmin desensitization versus those not.
• Monitoring of central visual fields to detect subclinical activity.
• Treatment with prednisone for patients with subclinical activity.

Main Results:

• Fifty percent of patients desensitized to histoplasmin showed subsequent activity, compared to 44% of controls.
• Prednisone treatment led to remission of subclinical activity in monitored patients.

Conclusions:

• Histoplasmin desensitization did not demonstrate a significant protective effect against subsequent ocular disease activity.
• Prednisone-induced remission is a valuable therapeutic strategy for managing subclinical ocular inflammation in affected patients.